Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
20 Julho 2023 - 9:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that it will issue
its financial results for the fiscal 2023 third quarter ended June
30, 2023, before the opening of the market on Friday, August 4,
2023. The company plans to hold a conference call and live audio
webcast for analysts and investors at 8:00 a.m. Eastern Time to
discuss its financial results and provide an update on the
company’s business. The press release with the financial results
will be accessible from the company’s website prior to the
conference call through the Investor Relations section under the
“Company” tab at www.twistbioscience.com.
The conference call will be webcast live through the Investor
Relations section under the “Company” tab at
www.twistbioscience.com. Those parties interested in participating
via telephone must register on the Company’s Investor Relations
website or by clicking here. Upon registration, all telephone
participants will receive the dial-in number along with a unique
PIN number that can be used to access the call. To avoid delays, we
encourage participants to dial into the conference call fifteen
minutes ahead of the scheduled start time. The webcast replay will
be available for two weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230720233271/en/
For Twist Bioscience: Angela Bitting SVP, Corporate
Affairs 925-202-6211 abitting@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Twist Bioscience (NASDAQ:TWST)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024